|Articles|July 2, 2023
- Pharmaceutical Executive: July 2023
- Volume 43
- Issue 7
Pharmaceutical Executive, July 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive June 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 3 years ago
Crossing the Brain Barrierabout 3 years ago
Biotech’s Survival Story: Companies Bear Down for Lean Yearsabout 3 years ago
Harnessing AI for Pharma Salesabout 3 years ago
Tapping New and Improved Drug Innovations in Asiaabout 3 years ago
Drug Shortages Continue to Plague FDA, Manufacturersabout 3 years ago
Contrasting Aims Highlight Pharma Reform Pursuitsabout 3 years ago
Shifting Macro Trends Offer Hope for Biotech Performance Boostabout 3 years ago
‘Bolus’ Markets: Unique Business Opportunities with Promise and RiskAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
How MBA Graduates Can Break into Competitive Industries in 2026: 4 Practical Steps
2
Pharma M&A Roundup: Oak Hill Bio Combines with RACC, Apnimed Plans $150 Million IPO, CORE Biomedicine Secures $21 Million Series A
3
FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients
4
Moving From Symptom Management to Disease Modification in Parkinson’s Research: Q&A with Dr. Jan Stoehr
5